Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

William Robinson to Mice

This is a "connection" page, showing publications William Robinson has written about Mice.

 
Connection Strength
 
 
 
0.204
 
  1. Couts KL, Bemis J, Turner JA, Bagby SM, Murphy D, Christiansen J, Hintzsche JD, Le A, Pitts TM, Wells K, Applegate A, Amato C, Multani P, Chow-Maneval E, Tentler JJ, Shellman YG, Rioth MJ, Tan AC, Gonzalez R, Medina T, Doebele RC, Robinson WA. ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms. Mol Cancer Ther. 2018 01; 17(1):222-231.
    View in: PubMed
    Score: 0.048
  2. Mukherjee N, Dart CR, Amato CM, Honig-Frand A, Lambert JR, Lambert KA, Robinson WA, Tobin RP, McCarter MD, Couts KL, Fujita M, Norris DA, Shellman YG. Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics. J Invest Dermatol. 2022 07; 142(7):1912-1922.e7.
    View in: PubMed
    Score: 0.016
  3. Mukherjee N, Skees J, Todd KJ, West DA, Lambert KA, Robinson WA, Amato CM, Couts KL, Van Gulick R, MacBeth M, Nassar K, Tan AC, Zhai Z, Fujita M, Bagby SM, Dart CR, Lambert JR, Norris DA, Shellman YG. MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell Death Dis. 2020 06 08; 11(6):443.
    View in: PubMed
    Score: 0.014
  4. Sinik L, Minson KA, Tentler JJ, Carrico J, Bagby SM, Robinson WA, Kami R, Burstyn-Cohen T, Eckhardt SG, Wang X, Frye SV, Earp HS, DeRyckere D, Graham DK. Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma. Mol Cancer Ther. 2019 02; 18(2):278-288.
    View in: PubMed
    Score: 0.013
  5. Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, Robinson WA, Messersmith WA, Fujita M. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma. Cancer Res. 2018 12 01; 78(23):6561-6574.
    View in: PubMed
    Score: 0.013
  6. Mukherjee N, Lu Y, Almeida A, Lambert K, Shiau CW, Su JC, Luo Y, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget. 2017 Jul 18; 8(29):46801-46817.
    View in: PubMed
    Score: 0.012
  7. Mukherjee N, Almeida A, Partyka KA, Lu Y, Schwan JV, Lambert K, Rogers M, Robinson WA, Robinson SE, Applegate AJ, Amato CM, Luo Y, Fujita M, Norris DA, Shellman YG. Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments. Oncotarget. 2016 Dec 20; 7(51):84594-84607.
    View in: PubMed
    Score: 0.011
  8. Keysar SB, Astling DP, Anderson RT, Vogler BW, Bowles DW, Morton JJ, Paylor JJ, Glogowska MJ, Le PN, Eagles-Soukup JR, Kako SL, Takimoto SM, Sehrt DB, Umpierrez A, Pittman MA, Macfadden SM, Helber RM, Peterson S, Hausman DF, Said S, Leem TH, Goddard JA, Arcaroli JJ, Messersmith WA, Robinson WA, Hirsch FR, Varella-Garcia M, Raben D, Wang XJ, Song JI, Tan AC, Jimeno A. A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol. 2013 Aug; 7(4):776-90.
    View in: PubMed
    Score: 0.009
  9. Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012 Oct; 30(10):2100-13.
    View in: PubMed
    Score: 0.008
  10. Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol. 2012 Oct; 132(10):2440-2450.
    View in: PubMed
    Score: 0.008
  11. Gonzalez R, Salem P, Bunn PA, Zukiwski AA, Lamb R, Benjamin RS, Spitler L, Wedel N, Robinson WA. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Mol Biother. 1991 Dec; 3(4):192-6.
    View in: PubMed
    Score: 0.008
  12. Terzian T, Torchia EC, Dai D, Robinson SE, Murao K, Stiegmann RA, Gonzalez V, Boyle GM, Powell MB, Pollock PM, Lozano G, Robinson WA, Roop DR, Box NF. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell Melanoma Res. 2010 Dec; 23(6):781-94.
    View in: PubMed
    Score: 0.007
  13. Stork LC, Peterson VM, Rundus CH, Robinson WA. Interleukin-1 enhances murine granulopoiesis in vivo. Exp Hematol. 1988 Feb; 16(2):163-7.
    View in: PubMed
    Score: 0.006
  14. Rundus C, Peterson VM, Zapata-Sirvent R, Hansbrough J, Robinson WA. Vitamin E improves cell-mediated immunity in the burned mouse: a preliminary study. Burns Incl Therm Inj. 1984 Oct; 11(1):11-5.
    View in: PubMed
    Score: 0.005
  15. Hartmann D, Entringer MA, Vasil M, Robinson WA. The effect of bacterial infection on granulopoiesis. Proc Soc Exp Biol Med. 1981 May; 167(1):6-11.
    View in: PubMed
    Score: 0.004
  16. Hartmann DW, Entringer MA, Vasil ML, Robinson WA. Relationship between colony stimulating factor (CSF) and colony forming unit in culture (CFUc) in nonimmunized and immunized C57/Bl mice infected with Escherichia coli. Exp Hematol. 1980 Nov; 8(10):1222-31.
    View in: PubMed
    Score: 0.004
  17. Joshi JH, Entringer MA, Robinson WA. Bacterial stimulation of serum colony-stimulating activity and neutrophil production in germ-free mice. Proc Soc Exp Biol Med. 1979 Oct; 162(1):44-7.
    View in: PubMed
    Score: 0.003
  18. Bolin RW, Robinson WA. Control factors of granulopoiesis in human serum. Am J Hematol. 1979; 6(1):1-10.
    View in: PubMed
    Score: 0.003
  19. Robinson WA. Current concepts of abnormal stem cell proliferation in human disease. Acta Haematol. 1979; 62(5-6):331-7.
    View in: PubMed
    Score: 0.003
  20. Ward HP, Vautrin R, Kurnick J, Robinson WA. Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment. Proc Soc Exp Biol Med. 1974 Oct; 147(1):305-8.
    View in: PubMed
    Score: 0.002
  21. Mangalik A, Robinson WA. Cyclic neutropenia: the relationship between urine granulocyte colony stimulating activity and neutrophil count. Blood. 1973 Jan; 41(1):79-84.
    View in: PubMed
    Score: 0.002
  22. Wallner SF, Vautrin RM, Buerk C, Robinson WA, Peterson VM. The anemia of thermal injury: studies of erythropoiesis in vitro. J Trauma. 1982 Sep; 22(9):774-80.
    View in: PubMed
    Score: 0.001
  23. Triebel F, Robinson WA, Hayward AR, Goube de Laforest PG. Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T-lymphocyte lineage. Blood. 1981 Nov; 58(5):911-5.
    View in: PubMed
    Score: 0.001
  24. Hartmann D, Entringer M, Robinson WA, Vasil M, Drebing C, Morton N, True L. [Bacterial infection and the regulation of in vivo granulopoiesis]. Schweiz Med Wochenschr. 1981 Oct 10; 111(41):1531-3.
    View in: PubMed
    Score: 0.001
  25. Hartmann DW, Entringer MA, Robinson WA, Vasil ML, Drebing CJ, Morton NJ, True L. Regulation of granulopoiesis and distribution of granulocytes in early phase of bacterial infection. J Cell Physiol. 1981 Oct; 109(1):17-24.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)